Mirabegron

Mirabegron is prescribed to help adults manage an overactive bladder (OAB), easing symptoms such as urinary urgency, frequent urination, and urge urinary incontinence. This medication works by relaxing the bladder muscle, allowing the bladder to hold more urine & reducing sudden urges to urinate.

When used as directed by a healthcare provider, Mirabegron is generally well-tolerated and effective for many adults, with regular monitoring recommended during treatment. U.S. retail pharmacies may charge higher prices for Mirabegron. Some patients should consider using licensed Canadian pharmacies to obtain lower prices while continuing to follow their healthcare provider’s guidance on proper use.

Before you buy or take Mirabegron, review the following safety considerations:

• Increased Blood Pressure: Mirabegron can increase blood pressure. Monitor regularly, especially in patients with hypertension.
• Urinary Retention: It may increase the risk of urinary retention, particularly in people with bladder outlet obstruction or when used with antimuscarinic drugs.
• Cardiovascular Effects: Increased heart rate and palpitations have been reported. Use caution in patients with a history of cardiovascular disease.
• Hypersensitivity Reactions: Serious allergic reactions, including angioedema (swelling of the tongue, face, lips, or throat), have been reported. Discontinue Mirabegron immediately and seek emergency medical help if signs of an allergic reaction occur.

• Avoid using Mirabegron if you have severe, uncontrolled high blood pressure.
• Do not exceed the Mirabegron prescribed dose, as higher doses may raise the risk of side effects.
• Limit excessive caffeine and alcohol, which may worsen bladder symptoms or interact with other medications.

What Precautions Should Be Taken When Taking Mirabegron?

• Inform your provider before starting new medications, including prescription drugs, over-the-counter products, or supplements.
• Before taking Mirabegron, tell your healthcare provider if you have or have had:
  • High blood pressure
  • Heart rhythm disorders
  • Kidney disease
  • Liver disease
  • Bladder outlet obstruction or difficulty urinating
• Pediatric Use: Safety & effectiveness not established in children under 3 years. Approved oral suspension for pediatric patients ≥3 years with neurogenic detrusor overactivity.
• Pregnancy & Breastfeeding: Limited data are available on the use of Mirabegron during pregnancy. It should be used during pregnancy only if clearly needed. It is unknown whether Mirabegron passes into human breast milk. Discuss potential risks with your provider before breastfeeding.
• Kidney and Liver Impairment:
  • Not recommended in severe renal impairment (eGFR <15 mL/min/1.73 m²) or severe hepatic impairment (Child‑Pugh C).
  • Dose adjustments are required in moderate impairment.

• It should not be used in patients who have a known hypersensitivity to Mirabegron or any component of the formulation.

What Monitoring Is Required for Mirabegron?

Patients taking Mirabegron may require:

• Periodic blood pressure monitoring
• Assessment for urinary retention symptoms
• Watch for allergic reactions (swelling, rash, difficulty breathing)
• Clinical evaluation of cardiovascular symptoms may be required

The appropriate Mirabegron dose varies based on the treated condition, patient age, kidney and liver function, and whether it is used alone or in combination with other medications. Always follow your doctor’s instructions.

Mirabegron is a β3‑adrenergic receptor agonist used to treat overactive bladder (OAB). It works by relaxing the detrusor muscle of the bladder during the storage phase, which:

• Increases bladder capacity
• Reduces urinary urgency, frequency, and incontinence

Patients taking Mirabegron may experience the following side effects, which differ from person to person:

Patients prescribed Mirabegron for an overactive bladder should follow these administration guidelines:

• Swallow tablets whole with water.
• Do not crush, chew, or split the extended‑release tablets.
• Take at the same time each day to maintain steady levels.
• It can be taken with or without food.
• If you forget a dose, take it as soon as you remember. If it’s almost time for your next one, skip the missed dose. Do not double up to make up for a missed dose.

FDA-approved treatment options include beta-3 adrenergic agonists like Mirabegron and antimuscarinic medications such as oxybutynin and tolterodine. Each option has different benefits and side-effect profiles.

• Mirabegron offers similar effectiveness to antimuscarinic medications for overactive bladder while generally causing fewer bothersome side effects, particularly dry mouth and cognitive issues.
• Antimuscarinic drugs may still be appropriate for some patients, particularly when cost is a concern or when blood pressure elevation is a risk factor.

Mirabegron can interact with certain medications, particularly those that affect liver enzymes or bladder function. Some drugs may require dose adjustments or closer monitoring when used together.

• Heart Medicines (CYP2D6 Substrates):
  • Metoprolol
  • Flecainide
  • Propafenone
  • Desipramine

Dose adjustment and monitoring of the CYP2D6 substrate may be required.

• Digoxin (requires monitoring)
• Antimuscarinic (Anticholinergic) Overactive Bladder Medications:
  • Oxybutynin
  • Tolterodine
  • Solifenacin
  • Darifenacin

Combination therapy should be used with caution and under medical supervision.

Depending on a patient’s medical history, kidney function, and overall tolerance, alternative overactive bladder treatments may be considered. Always consult a provider before changing or switching medications.

Beta-3 Adrenergic Agonists

Antimuscarinic (Anticholinergic) Medications

Clinical trials have shown that Mirabegron significantly improves overactive bladder symptoms, including urinary urgency, frequency, and urge urinary incontinence, compared with placebo. While individual responses vary, many patients experience clinically meaningful symptom improvement, particularly when treatment is combined with bladder training and lifestyle measures. In real-world studies, around 39% of patients remained on Mirabegron after 12 months, reflecting sustained use in routine practice.

Many patients in the U.S. choose to purchase Mirabegron from Canada because prescription medications are often priced significantly lower than at U.S. retail pharmacies. Canada’s regulated drug pricing system allows licensed pharmacies to offer the same FDA-approved medications at reduced costs. When ordering Mirabegron online from Polar Bear Meds, eligible patients may save up to 90% compared to U.S. pharmacy prices. Actual savings can vary based on dosage strength, quantity, and availability.

Mirabegron Coupons Savings Programs

Polar Bear Meds is committed to making prescription medications more affordable by offering additional savings opportunities:

• Use the Mirabegron coupon code ‘WELCOMEPB10’ to receive 10% off your first order.
• Earn a $20 account credit for each verified referral.
• Price match guarantee on all medications.
• If you find an identical drug at a lower price at a verified Canadian online pharmacy, we will match that price.

This information is provided for educational purposes and does not substitute professional medical advice. Mirabegron should only be used after consulting a licensed medical expert. Always speak with your medical provider or pharmacist before starting, stopping, or adjusting any medication.

• https://www.ncbi.nlm.nih.gov/books/NBK538513/ https://www.mayoclinic.org/drugs-supplements/mirabegron-oral-route/description/drg-20075675
• https://my.clevelandclinic.org/health/drugs/19467-mirabegron-extended-release-oral-tablets
• https://medlineplus.gov/druginfo/meds/a612038.html
• https://www.drugs.com/mtm/mirabegron.html
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202611s011lbl.pdf